A Phase 2 Study to Evaluate the Safety and Effectiveness of Using the Litx BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) Who Are Candidates for Interventional Therapy.

Trial Profile

A Phase 2 Study to Evaluate the Safety and Effectiveness of Using the Litx BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) Who Are Candidates for Interventional Therapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Nov 2012

At a glance

  • Drugs Talaporfin (Primary)
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Light Sciences Oncology
  • Most Recent Events

    • 01 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jun 2010 Planned end date changed from Feb 2011 to May 2011 as reported by ClinicalTrials.gov.
    • 15 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top